Tumor imaging with 2 σ-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: A feasibility study

Journal of Nuclear Medicine

Volumn 45, Issue 11, 2004, Pages 1939-1945

  Van Waarde, Aren ^a   Buursma, Anne Rixt ^a   Hospers, Geke A P ^a   Kawamura, Kazunori ^b   Kobayashi, Tadayuki ^c   Ishii, Kenji ^b   Oda, Keiichi ^b   Ishiwata, Kiichi ^b   Vaalburg, Willem ^a   Elsinga, Philip H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c M's Science Corporation   (Japan)

Author keywords

receptors; Cellular proliferation; PET; SA4503; Tumor imaging

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 (4 FLUORPHENYL)PROPYL)PIPERAZINE; 1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1 (4 2' FLUOROETHOXY 3 METHOXYPHENETHYL) 4 (3 (4 FLUOROPHENYL)PROPYL)PIPERAZINE; DELTA OPIATE RECEPTOR; HALOPERIDOL; KETAMINE; PENTAZOCINE; RACLOPRIDE; RADIOLIGAND; UNCLASSIFIED DRUG; 1-(4-2'-FLUOROETHOXY-3-METHOXYPHENETHYL)-4-(3-(4-FLUOROPHENYL)PROPYL)PIPERAZINE; CARBON; DIAGNOSTIC AGENT; PIPERAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SIGMA OPIATE RECEPTOR;

AGED; ANIMAL CELL; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BINDING AND TRANSPORT; DRUG DISTRIBUTION; FEMALE; GLIOMA; GROWTH CURVE; HUMAN; HUMAN CELL; LIGAND BINDING; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTIBODY SPECIFICITY; EVALUATION; FEASIBILITY STUDY; METABOLIC CLEARANCE RATE; METABOLISM; NUDE RAT; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

AGED; ANIMALS; CARBON RADIOISOTOPES; CELL LINE, TUMOR; FEASIBILITY STUDIES; FEMALE; GLIOMA; HUMANS; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; PIPERAZINES; RADIOPHARMACEUTICALS; RATS; RATS, NUDE; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 16344385532     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv. 2000;74:211-218.
2. Bem WT, Thomas GE, Mamone JY, et al. Overexpression of sigma receptors in nonneural human tumors. Cancer Res. 1991;51:6558-6562.
3. Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995;55:408-413.
4. John CS, Bowen WD, Varma VM, McAfee JG, Moody TW. Sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci. 1995;56:2385-2392.
5. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T. Neuroactive neurosteroids as endogenous effectors for the sigma1 receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol. 1999;81:125-155.
6. Ueda H, Yoshida A, Tokuyama S, et al. Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci Res. 2001;41:33-40.
7. Quirion R, Bowen WD, Itzhak Y, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85-86.
8. Mach RH, Smith CR, al Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997;57:156-161.
9. Wheeler KT, Wang LM, Wallen CA, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer. 2000;82:1223-1232.
10. al Nabulsi I, Mach RH, Wang LM, et al. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells. Br J Cancer. 1999;81:925-933.
11. i in colon and mammary adenocarcinoma cells. Biochem Biophys Res Commun. 1996;219:219 -226.
12. Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res. 2002;62:313-322.
13. Brent PJ, Pang GT. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur J Pharmacol. 1995;278:151-160.
14. Barbieri F, Sparatore A, Alama A, Novelli F, Bruzzo C, Sparatore F. Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancer. Oncol Res. 2003;13:455-461.
15. Matsuno K, Nakazawa M, Okamoto K, Kawashima Y, Mita S. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist. Eur J Pharmacol. 1996;306:271-279.
16. 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]- 4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. Nucl Med Biol. 2003;30:273-284.
17. 11C]SA4503 as a PET ligand for mapping CNS sigma1 receptors. Nucl Med Biol. 2000;27:255-261.
18. 11C]SA4503: radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain. Ann Nucl Med. 2000;14:285-292.
19. 11C]SA4503. Synapse. 2001;40:235-237.
20. Ishii K, Ishiwata K, Kimura Y, Kawamura K, Oda K, Senda M. Mapping of sigma-1 receptors in living human brain [abstract]. Neuroimage. 2001;13:S984.
21. Kawamura K, Kimura Y, Tsukada H, et al. An increase of sigma receptors in the aged monkey brain. Neurobiol Aging. 2003;24:745-752.
22. 18F]fluorinated sigma receptor ligands in the conscious monkey brain. Synapse. 2004;21:405-413.
23. Fujiwara T, Waterhouse RN, Yamamoto S, et al. Performance evaluation of a large axial field-of-view PET scanner: SET-2400W. Ann Nucl Med. 1997;11:307-313.
24. 18F-FE-SA5845 for tumor imaging [abstract]. J Nucl Med. 2001;42(suppl):84P.
25. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem. 1998;70:922-931.
26. Mei J, Pasternak GW. Molecular cloning and pharmacological characterization of the rat sigma1 receptor. Biochem Pharmacol. 2001;62:349-355.
27. 3H]SK&F 10,047 binding sites in rat liver. Eur J Pharmacol. 1988;147:259-264.
28. Roman F, Pascaud X, Chomette G, Bueno L, Junien JL. Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology. 1989;97:76-82.
29. Roman F, Pascaud X, Vauche D, Junien JL. Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus. Life Sci. 1988;42:2217-2222.
30. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol. 1994;268:9-18.
31. Liu Y, Whitlock BB, Pultz JA, Wolfe SA. Sigma-1 receptors modulate functional activity of rat splenocytes. J Neuroimmunol. 1995;59:143-154.
32. Paul R, Lavastre S, Floutard D, et al. Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747. J Neuroimmunol. 1994;52:183-192.
33. 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695-700.